Designer drugs on the internet: a phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly.

Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2-b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon.

[1]  J. Gewirtz,et al.  Behavioral Evidence for Interactions between a Hallucinogenic Drug and Group II Metabotropic Glutamate Receptors , 2000, Neuropsychopharmacology.

[2]  M. Farré,et al.  Psychoactive drug or mystical incense? Overview of the online available information on Spice products , 2009 .

[3]  E. sanders-Bush,et al.  Agonist-Directed Signaling of Serotonin 5-HT2C Receptors: Differences Between Serotonin and Lysergic Acid Diethylamide (LSD) , 1999, Neuropsychopharmacology.

[4]  Ornella Corazza Le nuove potenzialità della prevenzione digitale in materia di nuove droghe : il ruolo del Recreational Drugs European Network , 2010 .

[5]  D E Nichols,et al.  A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor. , 1998, Journal of medicinal chemistry.

[6]  A. Shulgin,et al.  PIHKAL: A Chemical Love Story , 1991 .

[7]  G. Aghajanian,et al.  LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. , 1996, The Journal of pharmacology and experimental therapeutics.

[8]  J. Chambers,et al.  Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT(2A/2C) receptor agonists. , 2001, Journal of medicinal chemistry.

[9]  D. Nelson,et al.  Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups. , 1996, Journal of medicinal chemistry.

[10]  R. Glennon,et al.  Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens , 2004, Psychopharmacology.

[11]  E. sanders-Bush,et al.  Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. , 1988, The Journal of pharmacology and experimental therapeutics.

[12]  M. Andreasen,et al.  A fatal poisoning involving Bromo-Dragonfly. , 2009, Forensic science international.

[13]  Fabrizio Schifano,et al.  Drugs on the web; the Psychonaut 2002 EU project , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[14]  J. Ramsey,et al.  Delayed onset of seizures and toxicity associated with recreational use of Bromo-dragonFLY , 2009, Journal of Medical Toxicology.

[15]  R. de la Torre,et al.  Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers. , 2008, Journal of pharmaceutical and biomedical analysis.

[16]  F. Vollenweider Advances and Pathophysiological Models of Hallucinogenic Drug Actions in Humans: A Preamble to Schizophrenia Research , 1998, Pharmacopsychiatry.

[17]  R. Glennon Do classical hallucinogens act as 5-HT2 agonists or antagonists? , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[18]  M. Perera Near-Death Experiences: Exploring the Mind-Body Connection , 2010 .

[19]  J. C. Winter,et al.  The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis , 1995, Psychopharmacology.